Work for Anixa Biosciences, Inc.?

Claim Your Profile

Anixa Biosciences, Inc. Logo Image

Anixa Biosciences, Inc.

Anixa Biosciences, Inc. Banner Image

About Anixa Biosciences, Inc.

1-10 Employees
Based in San Jose, California

Anixa is a publicly-traded biotechnology company developing a number of programs addressing cancer and infectious disease. Anixa's therapeutic portfolio includes a cancer immunotherapy program which uses a novel type of CAR-T, known as chimeric endocrine receptor T-cell (CER-T) technology, and a Covid-19 therapeutics program focused on inhibiting certain viral protein function. Anixa's vaccine portfolio consists of a technology focused on the immunization against a "retired" protein, α-Lactalbumin, to prevent triple negative breast cancer (TNBC), the most lethal form of breast cancer. Anixa continually examines emerging technologies in complementary fields for further development and commercialization.

Ticker:
ANIX
Exchange:
NASDAQ (See More NASDAQ Companies)
Industry:
Diagnostic Substances (See More Diagnostic Substances Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol